Bio: David Currow is Professor of Palliative & Supportive Services, Flinders University, Adelaide, South Australia.He has published more than 350 peer-reviewed articles, editorials and books and is an internationally recognized expert in palliative care research and in improving its delivery. He directs a busy research program which includes phase III and IV clinical trials, population-based studies using existing data bases, population-based surveys and codifying the evidence base underpinning palliative care. The unit he leads has more than 350 distance students around the world studying at post graduate level in palliative care. He is senior Associate Editor of Journal of Palliative Medicine and on the Editorial Boards of BMJ Supportive and Palliative Care, Journal of Pain and Symptom Management and the Journal of Oncology Practice. David is a former president of Palliative Care Australia and the Clinical Oncological Society of Australia.

Professor Currow will speak during "Dyspnea 2016", at the beginning of the afternoon session of June 16 2016, on "The management of clinical refractory dyspnea as a human right", with Pr Thomas Similowski as the session chairperson and discussant. 

Dyspnea 2016 message: "Every clinician has a responsibility to adequately assess and treat chronic refractory breathlessness.  This is highly prevalent in our community and there is a strong evidence base for its safe, symptomatic treatment."

Selected readings:
Laviolette L, Laveneziana P.
Dyspnoea: a multidimensional and multidisciplinary approach.
Eur Respir J 2014 Jun;43(6):1750-62

Currow DC, McDonald C, Oaten S, Kenny B, Allcroft P, Frith P, Briffa M, Johnson MJ, Abernethy AP.
Once-daily opioids for chronic dyspnoea: a dose increment and pharmacovigilance study.
J Pain Symptom Manage 2011;42(3):388-399

Parshall MB, et al.  
An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea.
Am J Respir Crit Care Med 2012; 185(4):435–452

Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C.
Randomised double-blind placebo-controlled crossover trial of sustained-release morphine for the management of refractory dyspnoea.
Br Med J 2003; 327(7414):523-8

Johnson MJ, Bland JM, Oxberry SG, Abernethy AP, Currow DC.
Clinically important differences in the intensity of chronic refractory breathlessness.
J Pain Symptom Manage 2013;46(6):957-63

-© Dyspnea2016inParis